Virologic and Immunologic Outcomes after 24 Weeks in HIV Type 1–Infected Adolescents Receiving Highly Active Antiretroviral Therapy
Patricia M. Flynn(St. Jude Children's Research Hospital), Jane C. Lindsey(Harvard University Press), Stephen A. Spector(University of California San Diego), Janet L. Lathey(University of California, San Diego), Steven D. Douglas(Purdue University West Lafayette), Jaime Martinez(John H. Stroger, Jr. Hospital of Cook County), Marvin Belzer(University of California, San Diego), James McNamara(National Institute of Allergy and Infectious Diseases), Janice Hodge(Frontier Science & Technology Research Foundation), Lawrence J. D’Angelo(Children's National), Michael D. Hughes(Harvard University), Bret J. Rudy(Columbia University Irving Medical Center), Lawrence B. Friedman(University of Miami), Margarita Silió(Tulane University)
Cited by 101
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Human monocytes and macrophages express substance P and neurokinin-1 receptor
|The Journal of Immunology|1997|386